Latus Bio Email Formats

Biotechnology Research • United States • 21-50 Employees

Latus Bio Email Formats

Latus Bio uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@latusbio.com), used 57.1% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@latusbio.com	57.1%
{first initial}.{last name}	j.doe@latusbio.com	28.6%
{first name}	john@latusbio.com	14.3%

Key Contacts at Latus Bio

Kerry Eischen

Director Of Quality Assurance

Michael Koniares

Senior Director, Finance And Business Operations

Diba Z.

Director Of Regulatory Affairs

Jenna Carroll Soper

Executive Director, Program Management

George Yohrling

Executive Director Of Development

Jamie Benoit

Senior Director, Biomarker Research

Company overview

Headquarters	United States
Website	latusbio.com
NAICS	541714
Founded	2022
Employees	21-50
Socials

About Latus Bio

At Latus Bio, we are developing novel therapeutics for CNS disorders with our revolutionary AAV capsids. We have developed capsid variants with unprecedented potency, specificity, and trophism. All of our capsids were designed with a particular disease in mind, in order to find the right capsid and the right route of administration to target the most relevant brain regions and cell types for each specific indication. Founded on the groundbreaking work of Professor Beverly Davidson from the Children's Hospital of Philadelphia, Latus Bio is committed to transforming patient care through targeted, potent, and safe gene therapies. We are focused on CNS diseases such as CLN2 (Batten Disease) and Huntington’s Disease, aiming to fundamentally alter the course of these challenging conditions by always putting the patients first. We are not just developing therapies; we are revolutionizing the future of healthcare with innovations that reduce therapeutic load, enhance safety, facilitate manufacturing, and expand access. Latus Bio is powered by a diverse team of visionary scientists, clinicians, and industry leaders dedicated to tackling some of the most complex neurological disorders. With a robust pipeline and a strategy to enter clinical trials by late 2025, we are poised to make significant strides quickly. Be part of this transformative movement at Latus Bio. Let's unlock the potential of gene therapy to bring hope and healing to millions around the globe. Learn more about our mission, our people, and our promise at www.latusbio.com and connect with us on LinkedIn to follow our progress.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Senior

Director

Entry

Employees by Department

Latus Bio has 14 employees across 8 departments.

Departments

Number of employees

Funding Data

Explore Latus Bio's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2024-06-02	4	$54,000,000

Funding Insights

$54,000,000

Total funding amount

$54,000,000

Most recent funding amount

Number of funding rounds

Latus Bio Tech Stack

Discover the technologies and tools that power Latus Bio's digital infrastructure, from frameworks to analytics platforms.

Cloudflare

CDN

Google Hosted Libraries

CDN

jQuery

JavaScript libraries

HTTP/3

Miscellaneous

HSTS

Security

Open Graph

Miscellaneous

Vimeo

Video players

GSAP

JavaScript frameworks

core-js

JavaScript libraries

Embedly

Widgets

Webflow

Page builders

cdnjs

CDN

Frequently asked questions

Latus Bio is located in US.

Latus Bio was founded in 2022, making it 4 years old. The company has established itself as a significant player in its industry over this time.

Latus Bio has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Latus Bio has raised a total of $54,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.